SPONSOR
Centre hospitalier de l'Université de Montréal (CHUM)
Total Trials
8
Recruiting
8
Phases
Phase 2, Phase 3
Conditions studied: Hepatocellular CarcinomaLiver CancerColorectal CancerPolyp of ColonALSFTDALS (Amyotrophic Lateral Sclerosis)Frontal Temporal Dementia (FTD)Oropharynx CancerRadiotherapy; ComplicationsRadiotherapy Side Effect
Centre hospitalier de l'Université de Montréal (CHUM) is a clinical research sponsor with 8 registered studies on ClinicalTrials.gov, of which 8 are actively recruiting participants. Research covers conditions including Hepatocellular Carcinoma, Liver Cancer, Colorectal Cancer, Polyp of Colon.
The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Centre hospitalier de l'Université de Montréal (CHUM)
How many clinical trials has Centre hospitalier de l'Université de Montréal (CHUM) sponsored?
ClinicalMetric currently tracks 8 clinical trials sponsored by Centre hospitalier de l'Université de Montréal (CHUM), of which 8 are actively recruiting participants. These trials cover conditions including Hepatocellular Carcinoma, Liver Cancer, Colorectal Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Centre hospitalier de l'Université de Montréal (CHUM) research focus on?
Centre hospitalier de l'Université de Montréal (CHUM) clinical trials span Hepatocellular Carcinoma, Liver Cancer, Colorectal Cancer, Polyp of Colon, ALSFTD, and additional conditions. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Centre hospitalier de l'Université de Montréal (CHUM) clinical trial?
To participate in a Centre hospitalier de l'Université de Montréal (CHUM) trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Centre hospitalier de l'Université de Montréal (CHUM) trials with current recruitment status updated daily.
Clinical Trials by Centre hospitalier de l'Université de Montréal (CHUM)
NCT06345508
Recruiting
Early Detection of Liver Cancer by QUS
Hepatocellular Carcinoma
NCT06271941
Recruiting
Reducing Neoplasia Recurrence After Endoscopic Resection of Large Colorectal Polyps
Colorectal Cancer
NCT06051123
Recruiting
Effects of Probiotics in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Spectrum Disorder (ALS-FTDSD) Patients
ALSFTD
NCT04901234 Phase 2
Recruiting
Adaptive RadioTherapy for OroPharynx Cancer
Oropharynx Cancer
NCT07354594 Phase 2
Recruiting
External Beam and Radioligand Radiotherapy for mCRPC
Prostate Cancer Metastatic Castration-Resistant
NCT04178174 Phase 3
Recruiting
Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer
Head and Neck Cancer
NCT03481075
Recruiting
Patient Specific Biomechanical Modeling of Abdominal Aortic Aneurysm to Improve Aortic Endovascular Repair
Aortic Aneurysm
NCT06615492
Recruiting
Routine vs On-demand ECMO for Lung Transplantation
Respiratory Failure
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology